Diaceutics PLC
Diaceutics PLC (LSE: DXRX) is trading at £1.92, about ₹244 at today's GBP/INR rate, as of 30 Sep 2026, 3:25 AM ET, up 1.86% today. Indian residents can buy Diaceutics from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
£1.89
Today's high
£1.92
52 week low
£1.25
52 week high
£1.97
DXRX opened at £1.89, closed previously at £1.89, and has traded between £1.25 and £1.97 over the past 52 weeks.
About
Diaceutics PLC, established in 2005 and headquartered in Belfast, UK, is a company dedicated to accelerating the commercialization of diagnostic solutions. It offers global pharmaceutical companies comprehensive data, advanced analytics, and implementation support. Central to its operations is the DXRX platform. This platform features DXRX data solutions, providing access to extensive diagnostic testing data pipelines from a broad network of laboratories, including real-time DXRX signal alerts, lab and physician mapping, and a testing dashboard. The DXRX platform also hosts a marketplace where laboratories, pharmaceutical firms, and diagnostic companies can connect to collaborate on precision medicine diagnostics. Diaceutics further provides DXRX Patient Journey, a tool for pharmaceutical clients to conduct detailed longitudinal analyses of individual patient biomarker testing paths, helping identify opportunities for earlier intervention and treatment. DXRX Lab Benchmarking allows laboratories to sharpen their competitive edge by comparing their key criteria against industry counterparts, encompassing metrics such as disease focus, testing methodologies, market share, turnaround times, and their standing as leaders in specific diagnostic fields. The DXRX Test Reimbursement service assists pharma clients in funding novel companion diagnostics, thereby shortening the time required for their widespread adoption. Furthermore, DXRX Test Signal delivers immediate notifications of testing events, empowering pharmaceutical clients to swiftly identify therapeutically actionable patients. Beyond the platform, Diaceutics furnishes services for diagnostic landscape analysis, strategic planning, implementation, and ongoing tracking, alongside expert consulting tailored to precision medicine diagnostics. Its extensive service portfolio also covers test standardization, quality evaluations, optimization of test reports, technical laboratory support, assistance with test access and reimbursement, laboratory training, and various educational resources.
Key statistics
Avg. volume
428.12K
Market cap
£162.49M
P/E Ratio
-600.00
Price-to-sales ratio
3.93
Enterprise value
£102.07M
Free cash flow yield
1.32%
Debt-to-equity ratio
0.05
Return on equity
0.24%
ROIC
0.26%
Beta
0.88
Dividend yield
0.00%
Last dividend
£0.00
Financial overview
Revenue
£38.44M
Earnings per share
£0.00
Free cash flow
£1.43M
Net profit margin
-0.66%
Gross margin
67.81%
EBITDA
£6.08M
Revenue growth
19.53%
Similar securities
This is not an investment recommendation
How to buy Diaceutics from India
Indian residents can buy Diaceutics shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to GBP.
Search for Diaceutics and place an order
Find Diaceutics by name or by its ticker, DXRX, and choose an order type. Diaceutics trades 12:30 pm – 9:00 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Diaceutics position in GBP and INR. Diaceutics pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Diaceutics from India
Trading and taxes when buying Diaceutics from India
Trading and limits
- Trading hours
- 8:00 am – 4:30 pm UK
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneDiaceutics does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
- Transaction tax
- The UK charges 0.5% Stamp Duty Reserve Tax when buying direct company shares electronically on the LSE; ETFs and UCITS funds do not attract it.
- Estate or inheritance tax
- May applyShares in UK-incorporated companies are UK-situs assets and fall within UK Inheritance Tax, charged at 40% above the £325,000 threshold for non-residents.Estate tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Diaceutics stock?
Yes. Diaceutics (DXRX) has been listed on the London Stock Exchange since 2019, in the Medical - Healthcare Information Services industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to GBP. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Diaceutics share cost in rupees?
One Diaceutics share is £1.92 — about ₹244 at a GBP/INR rate of 127.06 on 29 Sep 2026. Both the Diaceutics price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Diaceutics from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
How are gains on Diaceutics shares taxed in India?
Non-residents are exempt from UK capital gains tax on the disposal of listed shares, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the GBP/INR rate on the purchase and the sale date, so the rupee move counts alongside the Diaceutics price. Paasa issues a capital-gains statement for your return.
Does Diaceutics pay a dividend?
No. Diaceutics does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Diaceutics from India?
The London Stock Exchange trades 12:30 pm – 9:00 pm IST in Indian time. The window shifts to 1:30 pm – 10:00 pm IST when the UK is on standard time. Orders can only execute during that window.
Is there estate or inheritance tax on Diaceutics shares held from India?
Shares in UK-incorporated companies are UK-situs assets and fall within UK Inheritance Tax, charged at 40% above the £325,000 threshold for non-residents. It applies to your overall holdings in that jurisdiction rather than to any one position.
Are there transaction taxes when buying Diaceutics?
The UK charges 0.5% Stamp Duty Reserve Tax when buying direct company shares electronically on the LSE; ETFs and UCITS funds do not attract it. This is charged by the market, not by Paasa.
Do I have to declare Diaceutics shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Diaceutics holding, its cost and its closing value.
How do I sell Diaceutics and bring the money back to India?
You sell during market hours (12:30 pm – 9:00 pm IST) and the proceeds settle in GBP in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.